Lataa...
Current Overview on Hypercoagulability in COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboem...
Tallennettuna:
| Julkaisussa: | Am J Cardiovasc Drugs |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398761/ https://ncbi.nlm.nih.gov/pubmed/32748336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00431-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|